Daniel Walsh
Vorstandsvorsitzender bei Citymark Capital U.S. Apartment Fund II
Profil
Daniel Walsh is the founder of Citymark Capital U.S.
Apartment Fund II LP (Ohio), which was founded in 2015.
He held the title of Chief Executive Officer at the firm.
Currently, Mr. Walsh is working at Courtagen Life Sciences, Inc. as Vice President-Sales since 2012.
Mr. Walsh has previously worked at Pfizer Pharmaceuticals, Inc. and the US Department of the Navy (District of Columbia) as a Principal.
He completed his undergraduate degree at the University of Notre Dame.
Aktive Positionen von Daniel Walsh
Unternehmen | Position | Beginn |
---|---|---|
Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Vertrieb & Marketing | 01.01.2012 |
Citymark Capital U.S. Apartment Fund II
Citymark Capital U.S. Apartment Fund II Investment ManagersFinance Citymark Capital U.S. The private company is based in Cleveland, OH and has subsidiaries in the United States. Apartment Fund II LP is a company that functions as a private equity fund. The company was founded by Daniel Walsh, who has been the CEO since incorporation. | Vorstandsvorsitzender | 01.02.2015 |
Ehemalige bekannte Positionen von Daniel Walsh
Unternehmen | Position | Ende |
---|---|---|
US Department of the Navy (District of Columbia) | Corporate Officer/Principal | - |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | - |
Ausbildung von Daniel Walsh
University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Electronic Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
US Department of the Navy (District of Columbia) | Government |
Citymark Capital U.S. Apartment Fund II
Citymark Capital U.S. Apartment Fund II Investment ManagersFinance Citymark Capital U.S. The private company is based in Cleveland, OH and has subsidiaries in the United States. Apartment Fund II LP is a company that functions as a private equity fund. The company was founded by Daniel Walsh, who has been the CEO since incorporation. | Finance |